nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfuzosin—Doxazosin—Donepezil—Alzheimer's disease	0.718	1	CrCrCtD
Alfuzosin—CYP3A4—Rivastigmine—Alzheimer's disease	0.0469	0.432	CbGbCtD
Alfuzosin—CYP3A4—Donepezil—Alzheimer's disease	0.0375	0.345	CbGbCtD
Alfuzosin—CYP3A4—Galantamine—Alzheimer's disease	0.0241	0.223	CbGbCtD
Alfuzosin—Prazosin—MT3—Alzheimer's disease	0.00316	0.888	CrCbGaD
Alfuzosin—Injury—Galantamine—Alzheimer's disease	0.000829	0.00577	CcSEcCtD
Alfuzosin—Cardiovascular disorder—Rivastigmine—Alzheimer's disease	0.000822	0.00572	CcSEcCtD
Alfuzosin—Arthropathy—Memantine—Alzheimer's disease	0.000812	0.00565	CcSEcCtD
Alfuzosin—Atrial fibrillation—Galantamine—Alzheimer's disease	0.000804	0.00559	CcSEcCtD
Alfuzosin—Arthropathy—Rivastigmine—Alzheimer's disease	0.000795	0.00553	CcSEcCtD
Alfuzosin—Arthritis—Galantamine—Alzheimer's disease	0.000784	0.00545	CcSEcCtD
Alfuzosin—Influenza like illness—Memantine—Alzheimer's disease	0.000717	0.00499	CcSEcCtD
Alfuzosin—Influenza like illness—Rivastigmine—Alzheimer's disease	0.000702	0.00488	CcSEcCtD
Alfuzosin—Abdominal pain upper—Galantamine—Alzheimer's disease	0.000696	0.00484	CcSEcCtD
Alfuzosin—Orthostatic hypotension—Galantamine—Alzheimer's disease	0.000696	0.00484	CcSEcCtD
Alfuzosin—Neuropathy—Memantine—Alzheimer's disease	0.000693	0.00483	CcSEcCtD
Alfuzosin—Neuropathy—Rivastigmine—Alzheimer's disease	0.000678	0.00472	CcSEcCtD
Alfuzosin—Injury—Donepezil—Alzheimer's disease	0.000642	0.00447	CcSEcCtD
Alfuzosin—ADRA1D—forebrain—Alzheimer's disease	0.000635	0.103	CbGeAlD
Alfuzosin—Bronchitis—Galantamine—Alzheimer's disease	0.000633	0.00441	CcSEcCtD
Alfuzosin—Atrial fibrillation—Donepezil—Alzheimer's disease	0.000623	0.00434	CcSEcCtD
Alfuzosin—Upper respiratory tract infection—Galantamine—Alzheimer's disease	0.000612	0.00426	CcSEcCtD
Alfuzosin—Arthritis—Donepezil—Alzheimer's disease	0.000608	0.00423	CcSEcCtD
Alfuzosin—Osteoarthritis—Donepezil—Alzheimer's disease	0.000591	0.00411	CcSEcCtD
Alfuzosin—ADRA1D—telencephalon—Alzheimer's disease	0.000584	0.0948	CbGeAlD
Alfuzosin—Injury—Memantine—Alzheimer's disease	0.000583	0.00406	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Galantamine—Alzheimer's disease	0.000576	0.004	CcSEcCtD
Alfuzosin—Injury—Rivastigmine—Alzheimer's disease	0.000571	0.00397	CcSEcCtD
Alfuzosin—Atrial fibrillation—Memantine—Alzheimer's disease	0.000566	0.00394	CcSEcCtD
Alfuzosin—Hepatobiliary disease—Galantamine—Alzheimer's disease	0.000555	0.00386	CcSEcCtD
Alfuzosin—Atrial fibrillation—Rivastigmine—Alzheimer's disease	0.000554	0.00385	CcSEcCtD
Alfuzosin—Arthritis—Memantine—Alzheimer's disease	0.000552	0.00384	CcSEcCtD
Alfuzosin—Arthritis—Rivastigmine—Alzheimer's disease	0.00054	0.00376	CcSEcCtD
Alfuzosin—Abdominal pain upper—Donepezil—Alzheimer's disease	0.000539	0.00375	CcSEcCtD
Alfuzosin—Orthostatic hypotension—Donepezil—Alzheimer's disease	0.000539	0.00375	CcSEcCtD
Alfuzosin—Osteoarthritis—Memantine—Alzheimer's disease	0.000536	0.00373	CcSEcCtD
Alfuzosin—Rhinitis—Galantamine—Alzheimer's disease	0.000528	0.00368	CcSEcCtD
Alfuzosin—Osteoarthritis—Rivastigmine—Alzheimer's disease	0.000525	0.00365	CcSEcCtD
Alfuzosin—Urinary tract disorder—Galantamine—Alzheimer's disease	0.000521	0.00362	CcSEcCtD
Alfuzosin—Connective tissue disorder—Galantamine—Alzheimer's disease	0.000518	0.0036	CcSEcCtD
Alfuzosin—Urethral disorder—Galantamine—Alzheimer's disease	0.000517	0.0036	CcSEcCtD
Alfuzosin—Angina pectoris—Donepezil—Alzheimer's disease	0.000497	0.00346	CcSEcCtD
Alfuzosin—Eye disorder—Galantamine—Alzheimer's disease	0.000493	0.00343	CcSEcCtD
Alfuzosin—Bronchitis—Donepezil—Alzheimer's disease	0.000491	0.00342	CcSEcCtD
Alfuzosin—Orthostatic hypotension—Memantine—Alzheimer's disease	0.00049	0.00341	CcSEcCtD
Alfuzosin—Flushing—Galantamine—Alzheimer's disease	0.000489	0.0034	CcSEcCtD
Alfuzosin—Cardiac disorder—Galantamine—Alzheimer's disease	0.000489	0.0034	CcSEcCtD
Alfuzosin—Orthostatic hypotension—Rivastigmine—Alzheimer's disease	0.000479	0.00333	CcSEcCtD
Alfuzosin—Abdominal pain upper—Rivastigmine—Alzheimer's disease	0.000479	0.00333	CcSEcCtD
Alfuzosin—Angiopathy—Galantamine—Alzheimer's disease	0.000478	0.00333	CcSEcCtD
Alfuzosin—Breast disorder—Rivastigmine—Alzheimer's disease	0.000474	0.0033	CcSEcCtD
Alfuzosin—Mental disorder—Galantamine—Alzheimer's disease	0.000462	0.00321	CcSEcCtD
Alfuzosin—Infestation NOS—Donepezil—Alzheimer's disease	0.000455	0.00317	CcSEcCtD
Alfuzosin—Infestation—Donepezil—Alzheimer's disease	0.000455	0.00317	CcSEcCtD
Alfuzosin—Angina pectoris—Memantine—Alzheimer's disease	0.000451	0.00314	CcSEcCtD
Alfuzosin—Bronchitis—Memantine—Alzheimer's disease	0.000446	0.0031	CcSEcCtD
Alfuzosin—Back pain—Galantamine—Alzheimer's disease	0.000444	0.00309	CcSEcCtD
Alfuzosin—Jaundice—Donepezil—Alzheimer's disease	0.000444	0.00309	CcSEcCtD
Alfuzosin—Angina pectoris—Rivastigmine—Alzheimer's disease	0.000442	0.00307	CcSEcCtD
Alfuzosin—Sweating—Donepezil—Alzheimer's disease	0.000436	0.00304	CcSEcCtD
Alfuzosin—Bronchitis—Rivastigmine—Alzheimer's disease	0.000436	0.00303	CcSEcCtD
Alfuzosin—Upper respiratory tract infection—Memantine—Alzheimer's disease	0.000431	0.003	CcSEcCtD
Alfuzosin—Erectile dysfunction—Memantine—Alzheimer's disease	0.000427	0.00297	CcSEcCtD
Alfuzosin—Ill-defined disorder—Galantamine—Alzheimer's disease	0.000426	0.00296	CcSEcCtD
Alfuzosin—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.000421	0.00293	CcSEcCtD
Alfuzosin—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.000418	0.00291	CcSEcCtD
Alfuzosin—Malaise—Galantamine—Alzheimer's disease	0.000414	0.00288	CcSEcCtD
Alfuzosin—Infestation NOS—Memantine—Alzheimer's disease	0.000413	0.00287	CcSEcCtD
Alfuzosin—Infestation—Memantine—Alzheimer's disease	0.000413	0.00287	CcSEcCtD
Alfuzosin—Vertigo—Galantamine—Alzheimer's disease	0.000412	0.00287	CcSEcCtD
Alfuzosin—Syncope—Galantamine—Alzheimer's disease	0.000412	0.00286	CcSEcCtD
Alfuzosin—Rhinitis—Donepezil—Alzheimer's disease	0.00041	0.00285	CcSEcCtD
Alfuzosin—Palpitations—Galantamine—Alzheimer's disease	0.000406	0.00282	CcSEcCtD
Alfuzosin—Pharyngitis—Donepezil—Alzheimer's disease	0.000405	0.00282	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Memantine—Alzheimer's disease	0.000405	0.00282	CcSEcCtD
Alfuzosin—Drowsiness—Rivastigmine—Alzheimer's disease	0.000404	0.00281	CcSEcCtD
Alfuzosin—Infestation NOS—Rivastigmine—Alzheimer's disease	0.000404	0.00281	CcSEcCtD
Alfuzosin—Infestation—Rivastigmine—Alzheimer's disease	0.000404	0.00281	CcSEcCtD
Alfuzosin—Urinary tract disorder—Donepezil—Alzheimer's disease	0.000403	0.00281	CcSEcCtD
Alfuzosin—Loss of consciousness—Galantamine—Alzheimer's disease	0.000403	0.00281	CcSEcCtD
Alfuzosin—Urethral disorder—Donepezil—Alzheimer's disease	0.0004	0.00279	CcSEcCtD
Alfuzosin—Doxazosin—CYP2D6—Alzheimer's disease	0.000397	0.112	CrCbGaD
Alfuzosin—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.000396	0.00276	CcSEcCtD
Alfuzosin—Hepatobiliary disease—Memantine—Alzheimer's disease	0.000391	0.00272	CcSEcCtD
Alfuzosin—Arthralgia—Galantamine—Alzheimer's disease	0.000391	0.00272	CcSEcCtD
Alfuzosin—Chest pain—Galantamine—Alzheimer's disease	0.000391	0.00272	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000388	0.0027	CcSEcCtD
Alfuzosin—Sinusitis—Memantine—Alzheimer's disease	0.000388	0.0027	CcSEcCtD
Alfuzosin—Sweating—Rivastigmine—Alzheimer's disease	0.000388	0.0027	CcSEcCtD
Alfuzosin—Discomfort—Galantamine—Alzheimer's disease	0.000386	0.00269	CcSEcCtD
Alfuzosin—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.000382	0.00266	CcSEcCtD
Alfuzosin—Dry mouth—Galantamine—Alzheimer's disease	0.000382	0.00266	CcSEcCtD
Alfuzosin—Sinusitis—Rivastigmine—Alzheimer's disease	0.000379	0.00264	CcSEcCtD
Alfuzosin—Rhinitis—Memantine—Alzheimer's disease	0.000372	0.00259	CcSEcCtD
Alfuzosin—Shock—Galantamine—Alzheimer's disease	0.000368	0.00256	CcSEcCtD
Alfuzosin—Pharyngitis—Memantine—Alzheimer's disease	0.000368	0.00256	CcSEcCtD
Alfuzosin—Nervous system disorder—Galantamine—Alzheimer's disease	0.000367	0.00256	CcSEcCtD
Alfuzosin—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000367	0.00255	CcSEcCtD
Alfuzosin—Urinary tract disorder—Memantine—Alzheimer's disease	0.000366	0.00255	CcSEcCtD
Alfuzosin—Tachycardia—Galantamine—Alzheimer's disease	0.000366	0.00254	CcSEcCtD
Alfuzosin—ADRA1A—forebrain—Alzheimer's disease	0.000365	0.0592	CbGeAlD
Alfuzosin—Connective tissue disorder—Memantine—Alzheimer's disease	0.000364	0.00254	CcSEcCtD
Alfuzosin—Rhinitis—Rivastigmine—Alzheimer's disease	0.000364	0.00253	CcSEcCtD
Alfuzosin—Skin disorder—Galantamine—Alzheimer's disease	0.000364	0.00253	CcSEcCtD
Alfuzosin—Urethral disorder—Memantine—Alzheimer's disease	0.000364	0.00253	CcSEcCtD
Alfuzosin—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000362	0.00252	CcSEcCtD
Alfuzosin—Pharyngitis—Rivastigmine—Alzheimer's disease	0.00036	0.00251	CcSEcCtD
Alfuzosin—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000358	0.00249	CcSEcCtD
Alfuzosin—Mental disorder—Donepezil—Alzheimer's disease	0.000358	0.00249	CcSEcCtD
Alfuzosin—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000357	0.00248	CcSEcCtD
Alfuzosin—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000356	0.00247	CcSEcCtD
Alfuzosin—ADRA1B—nervous system—Alzheimer's disease	0.000352	0.0572	CbGeAlD
Alfuzosin—KCNH2—forebrain—Alzheimer's disease	0.000352	0.0572	CbGeAlD
Alfuzosin—Hypotension—Galantamine—Alzheimer's disease	0.00035	0.00243	CcSEcCtD
Alfuzosin—Eye disorder—Memantine—Alzheimer's disease	0.000347	0.00241	CcSEcCtD
Alfuzosin—ADRA1D—nervous system—Alzheimer's disease	0.000345	0.056	CbGeAlD
Alfuzosin—Cardiac disorder—Memantine—Alzheimer's disease	0.000344	0.0024	CcSEcCtD
Alfuzosin—Flushing—Memantine—Alzheimer's disease	0.000344	0.0024	CcSEcCtD
Alfuzosin—Back pain—Donepezil—Alzheimer's disease	0.000344	0.00239	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000341	0.00237	CcSEcCtD
Alfuzosin—ADRA1B—central nervous system—Alzheimer's disease	0.000339	0.0551	CbGeAlD
Alfuzosin—Eye disorder—Rivastigmine—Alzheimer's disease	0.000339	0.00236	CcSEcCtD
Alfuzosin—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000337	0.00234	CcSEcCtD
Alfuzosin—Flushing—Rivastigmine—Alzheimer's disease	0.000337	0.00234	CcSEcCtD
Alfuzosin—Angiopathy—Memantine—Alzheimer's disease	0.000337	0.00234	CcSEcCtD
Alfuzosin—ADRA1A—telencephalon—Alzheimer's disease	0.000335	0.0545	CbGeAlD
Alfuzosin—Mediastinal disorder—Memantine—Alzheimer's disease	0.000334	0.00233	CcSEcCtD
Alfuzosin—Somnolence—Galantamine—Alzheimer's disease	0.000333	0.00232	CcSEcCtD
Alfuzosin—ADRA1D—central nervous system—Alzheimer's disease	0.000332	0.0539	CbGeAlD
Alfuzosin—Ill-defined disorder—Donepezil—Alzheimer's disease	0.00033	0.0023	CcSEcCtD
Alfuzosin—Dyspepsia—Galantamine—Alzheimer's disease	0.00033	0.00229	CcSEcCtD
Alfuzosin—Angiopathy—Rivastigmine—Alzheimer's disease	0.000329	0.00229	CcSEcCtD
Alfuzosin—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000327	0.00228	CcSEcCtD
Alfuzosin—Mental disorder—Memantine—Alzheimer's disease	0.000325	0.00226	CcSEcCtD
Alfuzosin—KCNH2—telencephalon—Alzheimer's disease	0.000324	0.0526	CbGeAlD
Alfuzosin—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000323	0.00225	CcSEcCtD
Alfuzosin—Fatigue—Galantamine—Alzheimer's disease	0.000323	0.00225	CcSEcCtD
Alfuzosin—Malaise—Donepezil—Alzheimer's disease	0.000321	0.00223	CcSEcCtD
Alfuzosin—Constipation—Galantamine—Alzheimer's disease	0.00032	0.00223	CcSEcCtD
Alfuzosin—Vertigo—Donepezil—Alzheimer's disease	0.00032	0.00222	CcSEcCtD
Alfuzosin—Syncope—Donepezil—Alzheimer's disease	0.000319	0.00222	CcSEcCtD
Alfuzosin—Mental disorder—Rivastigmine—Alzheimer's disease	0.000318	0.00221	CcSEcCtD
Alfuzosin—Loss of consciousness—Donepezil—Alzheimer's disease	0.000313	0.00217	CcSEcCtD
Alfuzosin—Back pain—Memantine—Alzheimer's disease	0.000312	0.00217	CcSEcCtD
Alfuzosin—Feeling abnormal—Galantamine—Alzheimer's disease	0.000309	0.00215	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000306	0.00213	CcSEcCtD
Alfuzosin—Back pain—Rivastigmine—Alzheimer's disease	0.000306	0.00213	CcSEcCtD
Alfuzosin—Arthralgia—Donepezil—Alzheimer's disease	0.000303	0.00211	CcSEcCtD
Alfuzosin—Chest pain—Donepezil—Alzheimer's disease	0.000303	0.00211	CcSEcCtD
Alfuzosin—Ill-defined disorder—Memantine—Alzheimer's disease	0.0003	0.00208	CcSEcCtD
Alfuzosin—Discomfort—Donepezil—Alzheimer's disease	0.000299	0.00208	CcSEcCtD
Alfuzosin—Dry mouth—Donepezil—Alzheimer's disease	0.000296	0.00206	CcSEcCtD
Alfuzosin—Abdominal pain—Galantamine—Alzheimer's disease	0.000296	0.00206	CcSEcCtD
Alfuzosin—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000293	0.00204	CcSEcCtD
Alfuzosin—Malaise—Memantine—Alzheimer's disease	0.000291	0.00203	CcSEcCtD
Alfuzosin—Oedema—Donepezil—Alzheimer's disease	0.00029	0.00202	CcSEcCtD
Alfuzosin—Vertigo—Memantine—Alzheimer's disease	0.00029	0.00202	CcSEcCtD
Alfuzosin—Syncope—Memantine—Alzheimer's disease	0.00029	0.00201	CcSEcCtD
Alfuzosin—Infection—Donepezil—Alzheimer's disease	0.000288	0.00201	CcSEcCtD
Alfuzosin—Shock—Donepezil—Alzheimer's disease	0.000286	0.00199	CcSEcCtD
Alfuzosin—Palpitations—Memantine—Alzheimer's disease	0.000285	0.00199	CcSEcCtD
Alfuzosin—Malaise—Rivastigmine—Alzheimer's disease	0.000285	0.00198	CcSEcCtD
Alfuzosin—Nervous system disorder—Donepezil—Alzheimer's disease	0.000285	0.00198	CcSEcCtD
Alfuzosin—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000284	0.00198	CcSEcCtD
Alfuzosin—Vertigo—Rivastigmine—Alzheimer's disease	0.000284	0.00197	CcSEcCtD
Alfuzosin—Loss of consciousness—Memantine—Alzheimer's disease	0.000284	0.00197	CcSEcCtD
Alfuzosin—Syncope—Rivastigmine—Alzheimer's disease	0.000283	0.00197	CcSEcCtD
Alfuzosin—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000281	0.00195	CcSEcCtD
Alfuzosin—Palpitations—Rivastigmine—Alzheimer's disease	0.000279	0.00194	CcSEcCtD
Alfuzosin—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000278	0.00193	CcSEcCtD
Alfuzosin—Chest pain—Memantine—Alzheimer's disease	0.000275	0.00191	CcSEcCtD
Alfuzosin—Arthralgia—Memantine—Alzheimer's disease	0.000275	0.00191	CcSEcCtD
Alfuzosin—Discomfort—Memantine—Alzheimer's disease	0.000272	0.00189	CcSEcCtD
Alfuzosin—Hypotension—Donepezil—Alzheimer's disease	0.000271	0.00189	CcSEcCtD
Alfuzosin—ADRA1B—brain—Alzheimer's disease	0.000269	0.0437	CbGeAlD
Alfuzosin—Arthralgia—Rivastigmine—Alzheimer's disease	0.000269	0.00187	CcSEcCtD
Alfuzosin—Chest pain—Rivastigmine—Alzheimer's disease	0.000269	0.00187	CcSEcCtD
Alfuzosin—Dry mouth—Memantine—Alzheimer's disease	0.000269	0.00187	CcSEcCtD
Alfuzosin—Asthenia—Galantamine—Alzheimer's disease	0.000269	0.00187	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000267	0.00186	CcSEcCtD
Alfuzosin—Discomfort—Rivastigmine—Alzheimer's disease	0.000266	0.00185	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000264	0.00184	CcSEcCtD
Alfuzosin—Oedema—Memantine—Alzheimer's disease	0.000264	0.00183	CcSEcCtD
Alfuzosin—ADRA1D—brain—Alzheimer's disease	0.000263	0.0428	CbGeAlD
Alfuzosin—Dry mouth—Rivastigmine—Alzheimer's disease	0.000263	0.00183	CcSEcCtD
Alfuzosin—Infection—Memantine—Alzheimer's disease	0.000262	0.00182	CcSEcCtD
Alfuzosin—Shock—Memantine—Alzheimer's disease	0.000259	0.0018	CcSEcCtD
Alfuzosin—Nervous system disorder—Memantine—Alzheimer's disease	0.000258	0.0018	CcSEcCtD
Alfuzosin—Somnolence—Donepezil—Alzheimer's disease	0.000258	0.0018	CcSEcCtD
Alfuzosin—Thrombocytopenia—Memantine—Alzheimer's disease	0.000258	0.0018	CcSEcCtD
Alfuzosin—Oedema—Rivastigmine—Alzheimer's disease	0.000258	0.00179	CcSEcCtD
Alfuzosin—Tachycardia—Memantine—Alzheimer's disease	0.000257	0.00179	CcSEcCtD
Alfuzosin—Diarrhoea—Galantamine—Alzheimer's disease	0.000256	0.00178	CcSEcCtD
Alfuzosin—Infection—Rivastigmine—Alzheimer's disease	0.000256	0.00178	CcSEcCtD
Alfuzosin—Skin disorder—Memantine—Alzheimer's disease	0.000256	0.00178	CcSEcCtD
Alfuzosin—Dyspepsia—Donepezil—Alzheimer's disease	0.000255	0.00178	CcSEcCtD
Alfuzosin—Hyperhidrosis—Memantine—Alzheimer's disease	0.000255	0.00177	CcSEcCtD
Alfuzosin—Shock—Rivastigmine—Alzheimer's disease	0.000254	0.00176	CcSEcCtD
Alfuzosin—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000253	0.00176	CcSEcCtD
Alfuzosin—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000252	0.00176	CcSEcCtD
Alfuzosin—Tachycardia—Rivastigmine—Alzheimer's disease	0.000252	0.00175	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000251	0.00174	CcSEcCtD
Alfuzosin—Skin disorder—Rivastigmine—Alzheimer's disease	0.00025	0.00174	CcSEcCtD
Alfuzosin—Fatigue—Donepezil—Alzheimer's disease	0.00025	0.00174	CcSEcCtD
Alfuzosin—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000249	0.00173	CcSEcCtD
Alfuzosin—Constipation—Donepezil—Alzheimer's disease	0.000248	0.00173	CcSEcCtD
Alfuzosin—Pain—Donepezil—Alzheimer's disease	0.000248	0.00173	CcSEcCtD
Alfuzosin—Dizziness—Galantamine—Alzheimer's disease	0.000248	0.00172	CcSEcCtD
Alfuzosin—Hypotension—Memantine—Alzheimer's disease	0.000246	0.00171	CcSEcCtD
Alfuzosin—Hypotension—Rivastigmine—Alzheimer's disease	0.000241	0.00168	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.00024	0.00167	CcSEcCtD
Alfuzosin—Feeling abnormal—Donepezil—Alzheimer's disease	0.000239	0.00166	CcSEcCtD
Alfuzosin—Vomiting—Galantamine—Alzheimer's disease	0.000238	0.00166	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000237	0.00165	CcSEcCtD
Alfuzosin—Rash—Galantamine—Alzheimer's disease	0.000236	0.00164	CcSEcCtD
Alfuzosin—Dermatitis—Galantamine—Alzheimer's disease	0.000236	0.00164	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000235	0.00163	CcSEcCtD
Alfuzosin—Headache—Galantamine—Alzheimer's disease	0.000235	0.00163	CcSEcCtD
Alfuzosin—Somnolence—Memantine—Alzheimer's disease	0.000234	0.00163	CcSEcCtD
Alfuzosin—Dyspepsia—Memantine—Alzheimer's disease	0.000232	0.00161	CcSEcCtD
Alfuzosin—Urticaria—Donepezil—Alzheimer's disease	0.000231	0.0016	CcSEcCtD
Alfuzosin—Abdominal pain—Donepezil—Alzheimer's disease	0.000229	0.0016	CcSEcCtD
Alfuzosin—Somnolence—Rivastigmine—Alzheimer's disease	0.000229	0.00159	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000228	0.00158	CcSEcCtD
Alfuzosin—Fatigue—Memantine—Alzheimer's disease	0.000227	0.00158	CcSEcCtD
Alfuzosin—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000227	0.00158	CcSEcCtD
Alfuzosin—Constipation—Memantine—Alzheimer's disease	0.000225	0.00157	CcSEcCtD
Alfuzosin—Pain—Memantine—Alzheimer's disease	0.000225	0.00157	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000223	0.00155	CcSEcCtD
Alfuzosin—Nausea—Galantamine—Alzheimer's disease	0.000222	0.00155	CcSEcCtD
Alfuzosin—Fatigue—Rivastigmine—Alzheimer's disease	0.000222	0.00155	CcSEcCtD
Alfuzosin—Pain—Rivastigmine—Alzheimer's disease	0.00022	0.00153	CcSEcCtD
Alfuzosin—Constipation—Rivastigmine—Alzheimer's disease	0.00022	0.00153	CcSEcCtD
Alfuzosin—Feeling abnormal—Memantine—Alzheimer's disease	0.000217	0.00151	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000215	0.0015	CcSEcCtD
Alfuzosin—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000212	0.00148	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000211	0.00147	CcSEcCtD
Alfuzosin—Urticaria—Memantine—Alzheimer's disease	0.000209	0.00146	CcSEcCtD
Alfuzosin—Abdominal pain—Memantine—Alzheimer's disease	0.000208	0.00145	CcSEcCtD
Alfuzosin—Asthenia—Donepezil—Alzheimer's disease	0.000208	0.00145	CcSEcCtD
Alfuzosin—Pruritus—Donepezil—Alzheimer's disease	0.000205	0.00143	CcSEcCtD
Alfuzosin—Urticaria—Rivastigmine—Alzheimer's disease	0.000205	0.00142	CcSEcCtD
Alfuzosin—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000204	0.00142	CcSEcCtD
Alfuzosin—Diarrhoea—Donepezil—Alzheimer's disease	0.000199	0.00138	CcSEcCtD
Alfuzosin—ADRA1A—nervous system—Alzheimer's disease	0.000198	0.0322	CbGeAlD
Alfuzosin—Dizziness—Donepezil—Alzheimer's disease	0.000192	0.00134	CcSEcCtD
Alfuzosin—KCNH2—nervous system—Alzheimer's disease	0.000191	0.0311	CbGeAlD
Alfuzosin—ADRA1A—central nervous system—Alzheimer's disease	0.000191	0.031	CbGeAlD
Alfuzosin—Asthenia—Memantine—Alzheimer's disease	0.000189	0.00132	CcSEcCtD
Alfuzosin—Pruritus—Memantine—Alzheimer's disease	0.000186	0.0013	CcSEcCtD
Alfuzosin—ADRA1A—cerebellum—Alzheimer's disease	0.000186	0.0303	CbGeAlD
Alfuzosin—Asthenia—Rivastigmine—Alzheimer's disease	0.000185	0.00129	CcSEcCtD
Alfuzosin—Vomiting—Donepezil—Alzheimer's disease	0.000185	0.00128	CcSEcCtD
Alfuzosin—KCNH2—central nervous system—Alzheimer's disease	0.000184	0.0299	CbGeAlD
Alfuzosin—Rash—Donepezil—Alzheimer's disease	0.000183	0.00127	CcSEcCtD
Alfuzosin—Dermatitis—Donepezil—Alzheimer's disease	0.000183	0.00127	CcSEcCtD
Alfuzosin—Pruritus—Rivastigmine—Alzheimer's disease	0.000182	0.00127	CcSEcCtD
Alfuzosin—Headache—Donepezil—Alzheimer's disease	0.000182	0.00127	CcSEcCtD
Alfuzosin—Diarrhoea—Memantine—Alzheimer's disease	0.00018	0.00125	CcSEcCtD
Alfuzosin—KCNH2—cerebellum—Alzheimer's disease	0.00018	0.0292	CbGeAlD
Alfuzosin—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000176	0.00123	CcSEcCtD
Alfuzosin—Dizziness—Memantine—Alzheimer's disease	0.000174	0.00121	CcSEcCtD
Alfuzosin—Nausea—Donepezil—Alzheimer's disease	0.000172	0.0012	CcSEcCtD
Alfuzosin—Dizziness—Rivastigmine—Alzheimer's disease	0.00017	0.00119	CcSEcCtD
Alfuzosin—Vomiting—Memantine—Alzheimer's disease	0.000168	0.00117	CcSEcCtD
Alfuzosin—Rash—Memantine—Alzheimer's disease	0.000166	0.00116	CcSEcCtD
Alfuzosin—Dermatitis—Memantine—Alzheimer's disease	0.000166	0.00115	CcSEcCtD
Alfuzosin—Headache—Memantine—Alzheimer's disease	0.000165	0.00115	CcSEcCtD
Alfuzosin—Vomiting—Rivastigmine—Alzheimer's disease	0.000164	0.00114	CcSEcCtD
Alfuzosin—Rash—Rivastigmine—Alzheimer's disease	0.000163	0.00113	CcSEcCtD
Alfuzosin—Dermatitis—Rivastigmine—Alzheimer's disease	0.000162	0.00113	CcSEcCtD
Alfuzosin—Headache—Rivastigmine—Alzheimer's disease	0.000162	0.00112	CcSEcCtD
Alfuzosin—Nausea—Memantine—Alzheimer's disease	0.000157	0.00109	CcSEcCtD
Alfuzosin—Nausea—Rivastigmine—Alzheimer's disease	0.000153	0.00107	CcSEcCtD
Alfuzosin—ADRA1A—brain—Alzheimer's disease	0.000151	0.0246	CbGeAlD
Alfuzosin—KCNH2—brain—Alzheimer's disease	0.000146	0.0237	CbGeAlD
Alfuzosin—CYP3A4—nervous system—Alzheimer's disease	0.000118	0.0192	CbGeAlD
Alfuzosin—CYP3A4—central nervous system—Alzheimer's disease	0.000114	0.0185	CbGeAlD
Alfuzosin—ADRA1B—Signaling Pathways—HTR6—Alzheimer's disease	1.55e-05	0.000757	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—NPS—Alzheimer's disease	1.53e-05	0.000748	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—NPY—Alzheimer's disease	1.52e-05	0.000742	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—PLCB1—Alzheimer's disease	1.51e-05	0.000738	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—IAPP—Alzheimer's disease	1.51e-05	0.000738	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—GAB2—Alzheimer's disease	1.49e-05	0.000729	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—SST—Alzheimer's disease	1.49e-05	0.000729	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—CRH—Alzheimer's disease	1.46e-05	0.000716	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—SST—Alzheimer's disease	1.46e-05	0.000713	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—GAB2—Alzheimer's disease	1.46e-05	0.000713	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—APP—Alzheimer's disease	1.45e-05	0.000711	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR ligand binding—CCL2—Alzheimer's disease	1.43e-05	0.0007	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CDK5—Alzheimer's disease	1.43e-05	0.000698	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR ligand binding—F2—Alzheimer's disease	1.43e-05	0.000698	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—APP—Alzheimer's disease	1.42e-05	0.000695	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PSENEN—Alzheimer's disease	1.41e-05	0.000687	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—NPS—Alzheimer's disease	1.39e-05	0.000679	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—APH1A—Alzheimer's disease	1.39e-05	0.000678	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—PPP3CA—Alzheimer's disease	1.38e-05	0.000676	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—HTR6—Alzheimer's disease	1.37e-05	0.000672	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—PLCB1—Alzheimer's disease	1.37e-05	0.000671	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—A2M—Alzheimer's disease	1.36e-05	0.000667	CbGpPWpGaD
Alfuzosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	1.36e-05	0.000664	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—NCSTN—Alzheimer's disease	1.35e-05	0.00066	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—PRKCG—Alzheimer's disease	1.35e-05	0.000658	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—PLCB1—Alzheimer's disease	1.34e-05	0.000656	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—GAB2—Alzheimer's disease	1.32e-05	0.000648	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—SST—Alzheimer's disease	1.32e-05	0.000648	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PSEN2—Alzheimer's disease	1.32e-05	0.000646	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—LRP1—Alzheimer's disease	1.32e-05	0.000644	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—APP—Alzheimer's disease	1.29e-05	0.000631	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	1.29e-05	0.000629	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—GFAP—Alzheimer's disease	1.29e-05	0.000629	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—GAL—Alzheimer's disease	1.29e-05	0.000629	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—CCR5—Alzheimer's disease	1.27e-05	0.000623	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR ligand binding—CCL2—Alzheimer's disease	1.27e-05	0.000622	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PSENEN—Alzheimer's disease	1.25e-05	0.00061	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.25e-05	0.00061	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—APH1A—Alzheimer's disease	1.23e-05	0.000602	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—PRKCG—Alzheimer's disease	1.22e-05	0.000598	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—PLCB1—Alzheimer's disease	1.22e-05	0.000596	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—NPY—Alzheimer's disease	1.22e-05	0.000595	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—IAPP—Alzheimer's disease	1.21e-05	0.000591	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—NCSTN—Alzheimer's disease	1.2e-05	0.000586	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CRH—Alzheimer's disease	1.17e-05	0.000574	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—LRP1—Alzheimer's disease	1.17e-05	0.000572	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—CCR5—Alzheimer's disease	1.16e-05	0.000566	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—GAL—Alzheimer's disease	1.14e-05	0.000558	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—GFAP—Alzheimer's disease	1.14e-05	0.000558	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—HTR2A—Alzheimer's disease	1.13e-05	0.000554	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—A2M—Alzheimer's disease	1.13e-05	0.000554	CbGpPWpGaD
Alfuzosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	1.13e-05	0.000552	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—PRKCG—Alzheimer's disease	1.12e-05	0.000546	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—NPS—Alzheimer's disease	1.11e-05	0.000544	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PPP3CA—Alzheimer's disease	1.11e-05	0.000541	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PSEN2—Alzheimer's disease	1.1e-05	0.000536	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CA4—Alzheimer's disease	1.09e-05	0.000535	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—F2—Alzheimer's disease	1.09e-05	0.000535	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PTK2B—Alzheimer's disease	1.09e-05	0.000534	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—GAB2—Alzheimer's disease	1.06e-05	0.000519	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—NTRK2—Alzheimer's disease	1.06e-05	0.000519	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—SST—Alzheimer's disease	1.06e-05	0.000519	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—CCR5—Alzheimer's disease	1.06e-05	0.000517	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—CALM1—Alzheimer's disease	1.06e-05	0.000517	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—GSK3A—Alzheimer's disease	1.05e-05	0.000514	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.04e-05	0.000506	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—APP—Alzheimer's disease	1.03e-05	0.000506	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	1.03e-05	0.000503	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—PRKCG—Alzheimer's disease	1.01e-05	0.000496	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—NPY—Alzheimer's disease	1.01e-05	0.000494	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—A2M—Alzheimer's disease	1.01e-05	0.000492	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—IAPP—Alzheimer's disease	1e-05	0.000491	CbGpPWpGaD
Alfuzosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	1e-05	0.00049	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—F2—Alzheimer's disease	9.93e-06	0.000486	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—PRKCG—Alzheimer's disease	9.92e-06	0.000485	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PLCB1—Alzheimer's disease	9.76e-06	0.000477	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	9.75e-06	0.000477	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PSEN2—Alzheimer's disease	9.74e-06	0.000477	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CRH—Alzheimer's disease	9.74e-06	0.000476	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—CCR5—Alzheimer's disease	9.61e-06	0.00047	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—HTR2A—Alzheimer's disease	9.4e-06	0.00046	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—CCR5—Alzheimer's disease	9.4e-06	0.00046	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PLD3—Alzheimer's disease	9.3e-06	0.000455	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—NPS—Alzheimer's disease	9.23e-06	0.000452	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—HTR2A—Alzheimer's disease	9.2e-06	0.00045	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PPP3CA—Alzheimer's disease	9.19e-06	0.000449	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—NGFR—Alzheimer's disease	9.1e-06	0.000445	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—F2—Alzheimer's disease	9.08e-06	0.000444	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PTK2B—Alzheimer's disease	9.05e-06	0.000443	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—CREB1—Alzheimer's disease	9.05e-06	0.000443	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—PRKCG—Alzheimer's disease	9.01e-06	0.00044	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—NPY—Alzheimer's disease	8.97e-06	0.000439	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	8.92e-06	0.000436	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—IAPP—Alzheimer's disease	8.91e-06	0.000436	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—ADAM10—Alzheimer's disease	8.89e-06	0.000435	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—CCL2—Alzheimer's disease	8.85e-06	0.000433	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—NTRK2—Alzheimer's disease	8.81e-06	0.000431	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—GAB2—Alzheimer's disease	8.81e-06	0.000431	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—SST—Alzheimer's disease	8.81e-06	0.000431	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—CALM1—Alzheimer's disease	8.77e-06	0.000429	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—GSK3A—Alzheimer's disease	8.73e-06	0.000427	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CRH—Alzheimer's disease	8.65e-06	0.000423	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	8.59e-06	0.00042	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—APP—Alzheimer's disease	8.58e-06	0.00042	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—CCR5—Alzheimer's disease	8.53e-06	0.000417	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—S100B—Alzheimer's disease	8.41e-06	0.000411	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—HTR2A—Alzheimer's disease	8.35e-06	0.000408	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ND1—Alzheimer's disease	8.29e-06	0.000406	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—F2—Alzheimer's disease	8.24e-06	0.000403	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—NPS—Alzheimer's disease	8.2e-06	0.000401	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PPP3CA—Alzheimer's disease	8.16e-06	0.000399	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PLCB1—Alzheimer's disease	8.1e-06	0.000396	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—F2—Alzheimer's disease	8.06e-06	0.000394	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PTK2B—Alzheimer's disease	8.04e-06	0.000393	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—IGF2—Alzheimer's disease	8.01e-06	0.000392	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—GAB2—Alzheimer's disease	7.82e-06	0.000383	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—NTRK2—Alzheimer's disease	7.82e-06	0.000383	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—SST—Alzheimer's disease	7.82e-06	0.000383	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—CALM1—Alzheimer's disease	7.79e-06	0.000381	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—GSK3A—Alzheimer's disease	7.76e-06	0.000379	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—IGF1R—Alzheimer's disease	7.74e-06	0.000379	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—APP—Alzheimer's disease	7.62e-06	0.000373	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—NGFR—Alzheimer's disease	7.56e-06	0.00037	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—CREB1—Alzheimer's disease	7.51e-06	0.000367	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—LPL—Alzheimer's disease	7.42e-06	0.000363	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—ADAM10—Alzheimer's disease	7.38e-06	0.000361	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—MEF2C—Alzheimer's disease	7.36e-06	0.00036	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—CCL2—Alzheimer's disease	7.35e-06	0.000359	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—F2—Alzheimer's disease	7.32e-06	0.000358	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PRKCG—Alzheimer's disease	7.22e-06	0.000353	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PLCB1—Alzheimer's disease	7.19e-06	0.000352	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—NGF—Alzheimer's disease	7.03e-06	0.000344	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—S100B—Alzheimer's disease	6.98e-06	0.000341	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CCR5—Alzheimer's disease	6.84e-06	0.000334	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—NGFR—Alzheimer's disease	6.71e-06	0.000328	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—HTR2A—Alzheimer's disease	6.69e-06	0.000327	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—CREB1—Alzheimer's disease	6.67e-06	0.000326	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—IGF2—Alzheimer's disease	6.65e-06	0.000325	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—ADAM10—Alzheimer's disease	6.56e-06	0.000321	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—CCL2—Alzheimer's disease	6.53e-06	0.000319	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—IGF1R—Alzheimer's disease	6.43e-06	0.000314	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CALM1—Alzheimer's disease	6.24e-06	0.000305	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—APOE—Alzheimer's disease	6.22e-06	0.000304	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—LEP—Alzheimer's disease	6.22e-06	0.000304	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—S100B—Alzheimer's disease	6.2e-06	0.000303	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CAV1—Alzheimer's disease	6.16e-06	0.000301	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—LPL—Alzheimer's disease	6.16e-06	0.000301	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—MEF2C—Alzheimer's disease	6.11e-06	0.000299	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PRKCG—Alzheimer's disease	5.99e-06	0.000293	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—ESR1—Alzheimer's disease	5.94e-06	0.000291	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—IGF2—Alzheimer's disease	5.9e-06	0.000289	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—F2—Alzheimer's disease	5.87e-06	0.000287	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—NGF—Alzheimer's disease	5.83e-06	0.000285	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—NOTCH1—Alzheimer's disease	5.74e-06	0.000281	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—IGF1R—Alzheimer's disease	5.71e-06	0.000279	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CCR5—Alzheimer's disease	5.68e-06	0.000278	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—HTR2A—Alzheimer's disease	5.55e-06	0.000272	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—LPL—Alzheimer's disease	5.47e-06	0.000268	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—MEF2C—Alzheimer's disease	5.42e-06	0.000265	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—GSK3B—Alzheimer's disease	5.39e-06	0.000264	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CREB1—Alzheimer's disease	5.34e-06	0.000261	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—TPI1—Alzheimer's disease	5.34e-06	0.000261	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CHAT—Alzheimer's disease	5.34e-06	0.000261	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PRKCG—Alzheimer's disease	5.32e-06	0.00026	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—INS—Alzheimer's disease	5.31e-06	0.00026	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CCL2—Alzheimer's disease	5.23e-06	0.000256	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—NGF—Alzheimer's disease	5.18e-06	0.000253	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CALM1—Alzheimer's disease	5.18e-06	0.000253	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—LEP—Alzheimer's disease	5.16e-06	0.000253	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—APOE—Alzheimer's disease	5.16e-06	0.000253	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—IGF1—Alzheimer's disease	5.14e-06	0.000251	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—MAOB—Alzheimer's disease	5.12e-06	0.000251	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CAV1—Alzheimer's disease	5.12e-06	0.00025	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CCR5—Alzheimer's disease	5.04e-06	0.000247	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—HTR2A—Alzheimer's disease	4.93e-06	0.000241	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	4.93e-06	0.000241	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—ESR1—Alzheimer's disease	4.93e-06	0.000241	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—F2—Alzheimer's disease	4.87e-06	0.000238	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—NOTCH1—Alzheimer's disease	4.77e-06	0.000233	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—A2M—Alzheimer's disease	4.76e-06	0.000233	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—NOS3—Alzheimer's disease	4.66e-06	0.000228	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CALM1—Alzheimer's disease	4.6e-06	0.000225	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—LEP—Alzheimer's disease	4.59e-06	0.000224	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—APOE—Alzheimer's disease	4.59e-06	0.000224	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CAV1—Alzheimer's disease	4.54e-06	0.000222	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—GSK3B—Alzheimer's disease	4.47e-06	0.000219	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CREB1—Alzheimer's disease	4.44e-06	0.000217	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—INS—Alzheimer's disease	4.41e-06	0.000216	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—ESR1—Alzheimer's disease	4.38e-06	0.000214	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CCL2—Alzheimer's disease	4.34e-06	0.000212	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—F2—Alzheimer's disease	4.33e-06	0.000212	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—IGF1—Alzheimer's disease	4.27e-06	0.000209	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—NOTCH1—Alzheimer's disease	4.23e-06	0.000207	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ACHE—Alzheimer's disease	4.14e-06	0.000203	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	4.1e-06	0.0002	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—AKT1—Alzheimer's disease	3.99e-06	0.000195	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—GSK3B—Alzheimer's disease	3.97e-06	0.000194	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CASP3—Alzheimer's disease	3.96e-06	0.000194	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CREB1—Alzheimer's disease	3.94e-06	0.000193	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—IL6—Alzheimer's disease	3.93e-06	0.000192	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—INS—Alzheimer's disease	3.92e-06	0.000192	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	3.88e-06	0.00019	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ENO1—Alzheimer's disease	3.88e-06	0.00019	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—NOS3—Alzheimer's disease	3.87e-06	0.000189	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CCL2—Alzheimer's disease	3.86e-06	0.000189	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	3.81e-06	0.000186	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—IGF1—Alzheimer's disease	3.79e-06	0.000185	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—MAPK8—Alzheimer's disease	3.64e-06	0.000178	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—AKT1—Alzheimer's disease	3.63e-06	0.000177	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—BCHE—Alzheimer's disease	3.61e-06	0.000177	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—NOS3—Alzheimer's disease	3.44e-06	0.000168	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	3.41e-06	0.000167	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—VEGFA—Alzheimer's disease	3.36e-06	0.000164	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—AKT1—Alzheimer's disease	3.31e-06	0.000162	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	3.3e-06	0.000161	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CASP3—Alzheimer's disease	3.28e-06	0.000161	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—IL6—Alzheimer's disease	3.26e-06	0.00016	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—TGFB1—Alzheimer's disease	3.08e-06	0.000151	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—MAPK8—Alzheimer's disease	3.02e-06	0.000148	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—AKT1—Alzheimer's disease	3.01e-06	0.000147	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—AKT1—Alzheimer's disease	2.94e-06	0.000144	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CASP3—Alzheimer's disease	2.92e-06	0.000143	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—IL6—Alzheimer's disease	2.9e-06	0.000142	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	2.85e-06	0.000139	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	2.83e-06	0.000139	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—VEGFA—Alzheimer's disease	2.79e-06	0.000136	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—MAPK8—Alzheimer's disease	2.68e-06	0.000131	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—AKT1—Alzheimer's disease	2.67e-06	0.000131	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—LPL—Alzheimer's disease	2.59e-06	0.000127	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—TGFB1—Alzheimer's disease	2.56e-06	0.000125	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—TP53—Alzheimer's disease	2.54e-06	0.000124	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—VEGFA—Alzheimer's disease	2.48e-06	0.000121	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	2.33e-06	0.000114	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—IL6—Alzheimer's disease	2.32e-06	0.000114	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—TGFB1—Alzheimer's disease	2.27e-06	0.000111	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CALM1—Alzheimer's disease	2.18e-06	0.000107	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—APOE—Alzheimer's disease	2.17e-06	0.000106	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CAV1—Alzheimer's disease	2.15e-06	0.000105	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—AKT1—Alzheimer's disease	2.14e-06	0.000105	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—TP53—Alzheimer's disease	2.11e-06	0.000103	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—IL6—Alzheimer's disease	1.93e-06	9.43e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PPARG—Alzheimer's disease	1.89e-06	9.25e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—TP53—Alzheimer's disease	1.87e-06	9.15e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—INS—Alzheimer's disease	1.85e-06	9.07e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—AKT1—Alzheimer's disease	1.78e-06	8.7e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—IL6—Alzheimer's disease	1.71e-06	8.37e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—NOS3—Alzheimer's disease	1.63e-06	7.96e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—AKT1—Alzheimer's disease	1.58e-06	7.73e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	1.49e-06	7.28e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—AKT1—Alzheimer's disease	7.48e-07	3.66e-05	CbGpPWpGaD
